Inhibition of tRF‐16‐7X9PN5D promotes CRC cells' ability to proliferate, migrate and invade by directly targeting MKNK1 and may exert its molecular function through the MKNK‐ eIF4E axis. This evidence concerns the gene MKNK1 and colorectal carcinoma.